New provisions for researching severe hepatitis in adolescents
Keywords:
Hepatitis, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), AdenovirusAbstract
Globally, there has been an escalating number of new cases of severe hepatitis of unexplained etiology in apparently young, healthy adolescents. Jaundice and abdominal problems were the impacted adolescent's primary symptoms. This paper provides new research on severe hepatitis in adolescents. Although various workable hypotheses were present such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), adenovirus serotype 41, or SARS-CoV-2 superantigen-mediated immune cell activation, there was ultimately no established source or causes. Therefore, this study examines initial outbreak reports from 2022 that could help with identification, medication, and mitigation. The impact of this on surroundings is examined and explained so that a general conclusion can be drawn to understand this topic. This research is wholly based on reviews searched around the world. Some of the data collected are from the research papers of professionals and experts. Online searches and documents are studied for help. The main objective of this paper is to describe the new provisions for researching severe hepatitis in adolescents in today’s world and its impact on individuals and society.
Downloads
References
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721428/
Liakina V, Hamid S, Tanaka J, Olafsson S, Sharara AI, Alavian SM, et al. Historical epidemiology of hepatitis C virus (HCV) in select countries ‐ volume 3. J Viral Hepat 2015;22 Suppl 4:4‐20. [PubMed] [Google Scholar]
Lowe NJ, Rizk D, Grimes P, Billips M, Pincus S. Azelaic acid 20% cream in the treatment of facial hyperpigmentation in darker‐skinned patients. Clin Ther1998;20:945‐959. [PubMed] [Google Scholar]
Schwarz KB, Gonzalez‐Peralta RP, Murray KF, Molleston JP, Haber BA, Jonas MM, et al. The combination of ribavirin and peginterferon is superior to peginterferon and placebo for children and adolescents with chronic hepatitis C. Gastroenterology2011;140:450‐458e451. [PMC free article] [PubMed] [Google Scholar]
Indolfi G, Nesi A, Resti M. Intrafamilial transmission of hepatitis C virus. J Med Virol2013;85:608‐614. [PubMed] [Google Scholar]
Arafa N, El Hoseiny M, Rekacewicz C, Bakr I, El‐Kafrawy S, El Daly M, et al. Changing pattern of hepatitis C virus spread in rural areas of Egypt. J Hepatol2005;43:418‐424. [PubMed] [Google Scholar]
Plancoulaine S, Mohamed MK, Arafa N, Bakr I, Rekacewicz C, Tregouet DA, et al. Dissection of familial correlations in hepatitis C virus (HCV) seroprevalence suggests intrafamilial viral transmission and genetic predisposition to infection. Gut2008;57:1268‐1274. [PubMed] [Google Scholar]
Marsh K, Tayler R, Pollock L, Roy K, Lakha F, Ho A, et al. Investigation into cases of hepatitis of unknown aetiology among young children, Scotland, 1 January 2022 to 12 April 2022. Euro Surveill. 2022;27(15) doi: 10.2807/1560-7917.ES.2022.27.15.2200318. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240245/
ecdc.europa.eu [Internet]. Solna: European Centre for Disease Prevention and Control; Newsroom; Epidemiological update issued 19 May 2022: hepatitis of unknown aetiology in children; c2022 [updated 19 May 2022; cited 4 June 2022]. Available from: https://www.ecdc.europa.eu/en/news-events/epidemiological-update-issued-19-may-2022-hepatitis-unknown-aetiology-children
who.int [Internet]. Geneva: World Health Organization; Disease Outbreak News; Acute hepatitis of unknown aetiology in children - Multi-country; c2022 [updated 27 May 2022; cited 4 June 2022]. Available from: https://www.who.int/emergencies/disease-outbreak-news/item/DON-389.
ecdc.europa.eu [Internet]. Solna: European Centre for Disease Prevention and Control/WHO Regional Office for Europe; Hepatitis of Unknown Aetiology in Children, Joint Epidemiological overview, 31 May, 2022; c2022 [updated 31 May 2022; cited 4 June 2022]. Available from: https://cdn.ecdc.europa.eu/novhep-surveillance.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
